Skydive Beach Group Ltd

SKB Details
· Strong 1H 17 Performance driven by acquisitions: Skydive the Beach Group Ltd (ASX: SKB) stock rose over 6.14% on February 20, 2017 after the company reported solid first half 2017 results. The results for the six months to 31^st December 2016 included six months’ contribution from NZone Skydive and Skydive Wanaka and two months’ contribution from Raging Thunder Adventures, whereas the results for the six months to 31^st December 2015 included two months’ contribution from NZone Skydive. SKB in the 1H 2017 has reported for revenue growth of about 59%, EBITDA growth of 82.2% and the cash from operating activities growth of 192.1% across the SKB business. Moreover, SKB has successfully finished and integrated Skydive Wanaka and has raised $19.6m, oversubscribed by strong investor base in 1H 17. Additionally, SKB is looking to post 53.5% growth in the revenue and 61.5% growth in the EBITDA for FY17.

· Recommendation: We give a “Hold” recommendation at the current price of – $ 0.60
 

1H 17 Financial Performance (Source: Company Reports) 

Sirtex Medical Ltd

SRX Details
· Publication of combined SARAH/SIRveNIB Meta-Analysis study: Sirtex Medical Ltd.’s (ASX: SRX) stock surged over 3.11% on February 20, 2017. Recently, SRX has announced that the protocol for the combined prospective meta-analysis of the SARAH and SIRveNIB studies, known as the SIRveNIB and SARAH merge project (VESPRO) has been published in the Journal of Medical Internet Research (JMIR) Research Protocols. The group has also announced about reimbursement granted for refractory metastatic colorectal cancer in France. This is specific to SIR-Spheres Y-90 resin microspheres.

· Recommendation: SRX stock fell over 51.45% in the last six months (as of February 17, 2017) due to legal proceedings, and concerns over group’s trading updates along with CEO share trading. We give a “Hold” recommendation at the current price of – $ 15.58

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.